Sanofi (SNY) Short Interest Ratio & Short Volume → Forget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THIS (From Paradigm Press) (Ad) Free SNY Stock Alerts $49.13 -0.23 (-0.47%) (As of 04/26/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Sanofi Short Interest DataCurrent Short Volume3,240,000 sharesPrevious Short Volume3,900,000 sharesChange Vs. Previous Month-16.92%Dollar Volume Sold Short$149.82 millionShort Interest Ratio / Days to Cover1.6Last Record DateApril 15, 2024Outstanding Shares2,529,610,000 sharesShort Percent of Float0.13%Today's Trading Volume4,148,180 sharesAverage Trading Volume2,214,580 sharesToday's Volume Vs. Average187% Short Selling Sanofi ? Sign up to receive the latest short interest report for Sanofi and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatSNY Short Interest Over TimeSNY Days to Cover Over TimeSNY Percentage of Float Shorted Over Time Ad Prosper Trading AcademyThese AI trades triggered this morning (545% return)If you think a market crash is possible in 2024, I don't know why you're not using this yet. Click Here To Get Your Free Copy Sanofi Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/15/20243,240,000 shares $149.82 million -16.9%0.1%1.6 $46.24 3/31/20243,900,000 shares $189.54 million -15.0%0.2%2.1 $48.60 3/15/20244,590,000 shares $221.65 million +6.5%0.2%2.6 $48.29 2/29/20244,310,000 shares $206.23 million +6.2%0.2%2.4 $47.85 2/15/20244,060,000 shares $188.34 million -10.6%0.2%2.4 $46.39 1/31/20244,540,000 shares $226.55 million -19.7%0.2%2.6 $49.90 Get the Latest News and Ratings for SNY and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Sanofi and its competitors with MarketBeat's FREE daily newsletter. 1/15/20245,650,000 shares $294.99 million +22.3%0.2%2.8 $52.21 12/31/20234,620,000 shares $229.75 million +3.4%0.2%2.3 $49.73 12/15/20234,470,000 shares $213.13 million +13.7%0.2%2.1 $47.68 11/30/20233,930,000 shares $183.73 million +5.4%0.2%1.9 $46.75 11/15/20233,730,000 shares $169.42 million -25.4%0.2%1.9 $45.42 10/31/20235,000,000 shares $226.25 million +10.1%0.2%2.6 $45.25 10/15/20234,540,000 shares $247.57 million -0.4%0.2%3.1 $54.53 9/30/20234,560,000 shares $244.60 million +24.6%0.2%3.3 $53.64 9/15/20233,660,000 shares $199.62 million +7.0%0.2%3 $54.54 8/31/20233,420,000 shares $181.88 million +1.2%0.1%2.8 $53.18 8/15/20233,380,000 shares $178.46 million -18.9%0.1%2.7 $52.80 7/31/20234,170,000 shares $222.55 million -8.6%0.2%3.2 $53.37 7/15/20234,560,000 shares $240.22 million -6.6%0.2%3.5 $52.68 6/30/20234,880,000 shares $263.03 million +15.1%0.2%3.5 $53.90 6/15/20234,240,000 shares $219.59 million +11.3%0.2%2.7 $51.79 5/31/20233,810,000 shares $194.39 million +3.3%0.2%2.3 $51.02 5/15/20233,690,000 shares $201.25 million +2.8%0.2%2.1 $54.54 4/30/20233,590,000 shares $192.60 million No Change0.1%2 $53.65 4/15/20233,590,000 shares $201.58 million +23.4%0.1%1.9 $56.15 3/31/20232,910,000 shares $158.36 million +5.1%0.1%1.4 $54.42 3/15/20232,770,000 shares $131.77 million +1.1%0.1%1.4 $47.57 2/28/20232,740,000 shares $128.37 million +16.1%0.1%1.2 $46.85 2/15/20232,360,000 shares $111.51 million -12.9%0.1%1 $47.25 1/31/20232,710,000 shares $133.17 million -8.5%0.1%1.1 $49.14 1/15/20232,960,000 shares $145.84 million +6.9%0.1%1.1 $49.27 12/30/20222,770,000 shares $134.15 million -2.5%0.1%1 $48.43 12/15/20222,840,000 shares $133.93 million +11.4%0.1%0.9 $47.16 11/30/20222,550,000 shares $115.64 million -45.0%0.1%0.8 $45.35 11/15/20224,640,000 shares $202.07 million -12.6%0.2%1.6 $43.55 10/31/20225,310,000 shares $229.55 million +7.3%0.2%1.5 $43.23 10/15/20224,950,000 shares $195.92 million +34.2%0.2%1.5 $39.58 9/30/20223,690,000 shares $140.29 million -5.6%0.2%1.2 $38.02 9/15/20223,910,000 shares $159.02 million -18.4%0.2%1.3 $40.67 8/31/20224,790,000 shares $196.53 million +25.7%0.2%1.7 $41.03The “Next Bitcoin”? 10 CENT Crypto Set to Explode (Ad)The man who bought Bitcoin and Ethereum in 2017… and has spotted 44 different coins that have returned over 100%... Is now exposing a 10-cent coin that just partnered with Amazon…Click For My #1 FREE Crypto for 2024 SNY Short Interest - Frequently Asked Questions What is Sanofi's current short interest? Short interest is the volume of Sanofi shares that have been sold short but have not yet been covered or closed out. As of April 15th, investors have sold 3,240,000 shares of SNY short. 0.13% of Sanofi's shares are currently sold short. Learn More on Sanofi's current short interest. What is a good short interest ratio for Sanofi? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. SNY shares currently have a short interest ratio of 2.0. Learn More on Sanofi's short interest ratio. Which institutional investors are shorting Sanofi? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Sanofi: Concourse Financial Group Securities Inc.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. What is a good short interest percentage for Sanofi? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.13% of Sanofi's floating shares are currently sold short. Is Sanofi's short interest increasing or decreasing? Sanofi saw a decline in short interest during the month of April. As of April 15th, there was short interest totaling 3,240,000 shares, a decline of 16.9% from the previous total of 3,900,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Sanofi's short interest compare to its competitors? 0.13% of Sanofi's shares are currently sold short. Here is how the short interest of companies in the sector of "medical" compare to Sanofi: Vertex Pharmaceuticals Incorporated (1.56%), Bristol-Myers Squibb (1.69%), Regeneron Pharmaceuticals, Inc. (1.27%), Pfizer Inc. (1.20%), GSK plc (0.36%), Zoetis Inc. (0.70%), Abbott Laboratories (0.75%), Novartis AG (0.19%), Takeda Pharmaceutical Company Limited (0.19%), Biogen Inc. (2.26%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.70 billion), Occidental Petroleum Co. ($3.52 billion), Charter Communications, Inc. ($3.14 billion), General Motors ($2.68 billion), Coinbase Global, Inc. ($2.57 billion), Moderna, Inc. ($2.18 billion), Tractor Supply ($2.10 billion), Royal Caribbean Cruises Ltd. ($1.91 billion), TC Energy Co. ($1.90 billion), and Williams-Sonoma, Inc. ($1.78 billion). View all of the most shorted stocks. What does it mean to sell short Sanofi stock? Short selling SNY is an investing strategy that aims to generate trading profit from Sanofi as its price is falling. SNY shares are trading down $0.23 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Sanofi? A short squeeze for Sanofi occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of SNY, which in turn drives the price of the stock up even further. How often is Sanofi's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including SNY, twice per month. The most recent reporting period available is April, 15 2024. More Short Interest Resources from MarketBeat Related Companies: VRTX Short Interest Data BMY Short Interest Data REGN Short Interest Data PFE Short Interest Data GSK Short Interest Data ZTS Short Interest Data ABT Short Interest Data NVS Short Interest Data TAK Short Interest Data BIIB Short Interest Data Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:SNY) was last updated on 4/28/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingHis win rate puts Warren Buffett to shame… Investing DailyHe Is Giving Away BitcoinCrypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading AcademyBiden out June 13; Kamala won’t replace him?Paradigm PressJeff Bezos Just Humiliated Elon MuskInvestorPlace